The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle
- PMID: 11044558
- DOI: 10.1016/s0165-2427(00)00217-8
The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle
Abstract
Replication-competent and replication-defective bovine adenovirus type 3 recombinants expressing the bovine herpesvirus type 1 (BHV-1) glycoprotein D (gD) were tested for induction of gD specific immune responses in calves using intratracheal (1st and 2nd immunization) and sub-cutaneous (3rd immunization) route of immunization. The replication-defective recombinant BAV501 induced systemic immune responses against gD as low titers of anti gD-IgG were detected in the serum. However, the efficacy of the replication-competent BAV3.E3gD to induce gD-specific antibodies in the serum and the nasal secretions was superior to that of replication-defective BAV501 when both viruses were given at the same dosage. Partial protection from challenge was induced in calves immunized with replication-competent BAV3.E3gD. A dramatic increase in the titers of anti-gD IgG and IgA levels, both in serum and nasal secretions, following BHV-1 challenge (anamnestic response) suggested that the animals immunized with replication-defective BAV501 had been primed for gD-specific antibody responses.
Similar articles
-
Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.J Gen Virol. 1999 May;80 ( Pt 5):1263-1269. doi: 10.1099/0022-1317-80-5-1263. J Gen Virol. 1999. PMID: 10355773
-
Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.Vaccine. 2010 Apr 19;28(18):3159-70. doi: 10.1016/j.vaccine.2010.02.051. Epub 2010 Feb 26. Vaccine. 2010. PMID: 20189484 Free PMC article.
-
Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD.Virology. 1998 Oct 10;250(1):220-9. doi: 10.1006/viro.1998.9351. Virology. 1998. PMID: 9770436
-
DNA immunization with bovine herpesvirus-1 genes.Ann N Y Acad Sci. 1995 Nov 27;772:47-63. doi: 10.1111/j.1749-6632.1995.tb44731.x. Ann N Y Acad Sci. 1995. PMID: 8546413 Review. No abstract available.
-
A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines.Anim Health Res Rev. 2007 Dec;8(2):187-205. doi: 10.1017/S146625230700134X. Anim Health Res Rev. 2007. PMID: 18218160 Review.
Cited by
-
Use of adenoviral vectors as veterinary vaccines.Gene Ther. 2005 Oct;12 Suppl 1(Suppl 1):S73-83. doi: 10.1038/sj.gt.3302618. Gene Ther. 2005. PMID: 16231058 Free PMC article. Review.
-
Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD.PLoS One. 2013;8(1):e52758. doi: 10.1371/journal.pone.0052758. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23300989 Free PMC article.
-
Bovine adenovirus-3 as a vaccine delivery vehicle.Vaccine. 2015 Jan 15;33(4):493-9. doi: 10.1016/j.vaccine.2014.11.055. Epub 2014 Dec 9. Vaccine. 2015. PMID: 25498212 Free PMC article. Review.
-
Bovine Adenovirus-3 Tropism for Bovine Leukocyte Sub-Populations.Viruses. 2020 Dec 12;12(12):1431. doi: 10.3390/v12121431. Viruses. 2020. PMID: 33322850 Free PMC article.
-
Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.Clin Vaccine Immunol. 2009 Nov;16(11):1675-86. doi: 10.1128/CVI.00224-09. Epub 2009 Sep 30. Clin Vaccine Immunol. 2009. PMID: 19793901 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous